Page last updated: 2024-08-26

2,3,6-trimethyl-1,4-naphthoquinone and Parkinson Disease

2,3,6-trimethyl-1,4-naphthoquinone has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bai, R; Cai, H; Ge, J; He, X; Xie, T; Yao, C; Ye, XY; Zhong, Z; Zhu, J1
Budzianowski, J1

Reviews

2 review(s) available for 2,3,6-trimethyl-1,4-naphthoquinone and Parkinson Disease

ArticleYear
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Biological Products; Blood-Brain Barrier; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Parkinson Disease

2022
[Tobacco--once a medicinal plant. Does it contain substances with medicinal properties?].
    Przeglad lekarski, 2013, Volume: 70, Issue:10

    Topics: Animals; Brain; Comorbidity; Humans; Monoamine Oxidase; Naphthoquinones; Neuroprotective Agents; Nicotiana; Nicotine; Nitric Oxide Synthase Type I; Parkinson Disease; Phytotherapy; Plants, Medicinal; Receptors, Nicotinic; Smoking

2013